Pegylated liposomal doxorubicin + TOPOTECAN + Paclitaxel for fallopian tube neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Dec 2015: Trial registered, NCT02631876
  2. 2 Mar 2016: Trial started, NCT02631876

The trials

NCT02631876: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer

State
Completed
Phase
Phase 3
People
366 taking part
Started
2 Mar 2016
Primary completion
Jan 2019
Arms
Investigator's Choice (IC) Chemotherapy
Results
Posted on the registry
  1. 16 Dec 2015: Trial registered
  2. 2 Mar 2016: Trial started
  3. 9 Jun 2020: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.